{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:06:40Z","timestamp":1792786000149,"version":"4.5.0"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100009882","name":"Lombardy region","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009882","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EPIFARM-Pharmaco-epidemiology"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Kidney disease is a severe complication of systemic lupus erythematosus (SLE), often leading to kidney failure. Despite therapeutic advances, its management remains challenging. The aim of this study was to assess the association between SLE and renal outcomes and all-cause death, as well as their therapeutic management in a real-world setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>SLE patients were identified using administrative health databases from 2010 to 2019. The association between SLE and outcomes, compared to age and sex-matched controls, was reported as incidence rate and as adjusted hazard ratios. The frequency of pharmacological treatment was also analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included 2133 and 21 283 SLE and non-SLE individuals, respectively. SLE patients had a higher incidence rate and risk of composite renal outcome (20.2 vs 1.6\/1000 person years; adjusted Hazard Ratio [aHR] 7.85, 95% Confidence Interval [CI] 6.43\u20139.58) and all-cause death (17.4 vs 7.5\/1000 person years; aHR 1.78, 95% CI 1.53\u20132.07) as compared to non-SLE individuals. In SLE patients, adverse outcomes were observed early in the disease course, and particularly in younger individuals. A history of kidney disease was a strong predictor of kidney disease progression and mortality. Compared to non-SLE patients, those with SLE were more frequently prescribed glucocorticoids, conventional and biologic disease-modifying antirheumatic drugs (c-bDMARDs) and cardiovascular medications, with further increases in c-bDMARDs following a renal event.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings confirm increased risks of renal outcomes and mortality in SLE, especially with pre-existing kidney disease. Although we observed a preeminent use of immunosuppressive and nephroprotective medications in SLE patients with renal complications, additional data are needed to improve management strategies aimed at preventing kidney disease progression, especially early in the disease course and among younger individuals.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/joneph\/aajag138","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:39:06Z","timestamp":1778585946000},"page":"1462-1469","source":"Crossref","is-referenced-by-count":0,"title":["Renal outcomes and all-cause death in patients with systemic lupus erythematosus: insights from a population-based study in Northern Italy"],"prefix":"10.1093","volume":"39","author":[{"given":"Stefania","family":"Calvisi","sequence":"first","affiliation":[{"name":"Unit of General Medicine and Advanced Care, IRCCS Ospedale San Raffaele , Milan ,","place":["Italy"]},{"name":"Italian Society for Vascular Medicine , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0264-151X","authenticated-orcid":false,"given":"Marta","family":"Baviera","sequence":"additional","affiliation":[{"name":"Laboratory of Cardiovascular Prevention, Department of Health Policy, Istituto di Ricerche Farmacologiche Mario Negri IRCCS , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginevra","family":"Torrigiani","sequence":"additional","affiliation":[{"name":"Laboratory of Cardiovascular Prevention, Department of Health Policy, Istituto di Ricerche Farmacologiche Mario Negri IRCCS , Milan ,","place":["Italy"]},{"name":"Department of Statistics and Quantitative Methods, Universit\u00e0 Degli Studi di Milano-Bicocca, Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Fortino","sequence":"additional","affiliation":[{"name":"Directorate General for Health, Lombardy Region , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Tettamanti","sequence":"additional","affiliation":[{"name":"Laboratory of Geriatric Epidemiology, Department of Health Policy, Istituto di Ricerche Farmacologiche Mario Negri IRCCS , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2920-1669","authenticated-orcid":false,"given":"Luisa","family":"Ojeda-Fernandez","sequence":"additional","affiliation":[{"name":"Laboratory of Cardiovascular Prevention, Department of Health Policy, Istituto di Ricerche Farmacologiche Mario Negri IRCCS , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"2026102121380263700_aajag138-B1","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1001\/jama.2024.2315","article-title":"Systemic lupus erythematosus: a review","volume":"331","author":"Siegel","year":"2024","journal-title":"JAMA"},{"key":"2026102121380263700_aajag138-B2","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1136\/annrheumdis-2020-216924","article-title":"2019 update of\u00a0the joint European League Against Rheumatism and European\u00a0Renal Association-European Dialysis and Transplant Association (EULAR\/ERA-EDTA) recommendations for the management of lupus nephritis","volume":"79","author":"Fanouriakis","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2026102121380263700_aajag138-B3","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/jalm\/jfac036","article-title":"A review of lupus nephritis","volume":"7","author":"Alforaih","year":"2022","journal-title":"Appl Lab Med"},{"key":"2026102121380263700_aajag138-B4","doi-asserted-by":"publisher","first-page":"3934","DOI":"10.1002\/art.20666","article-title":"Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial","volume":"50","author":"Houssiau","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2026102121380263700_aajag138-B5","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/rheumatology\/kev311","article-title":"The frequency and outcome of lupus nephritis: results from an international inception cohort study","volume":"55","author":"Hanly","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"2026102121380263700_aajag138-B6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/ard-2023-224762","article-title":"EULAR recommendations for the management of systemic lupus erythematosus: 2023 update","volume":"83","author":"Fanouriakis","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"2026102121380263700_aajag138-B7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1136\/annrheumdis-2020-218272","article-title":"Update on the diagnosis and management of systemic lupus erythematosus","volume":"80","author":"Fanouriakis","year":"2021","journal-title":"Ann\u00a0Rheum Dis"},{"key":"2026102121380263700_aajag138-B8","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1093\/rheumatology\/keae496","article-title":"Incidence and risk of arterial and venous thrombotic events in systemic lupus erythematosus patients: a population-based study","volume":"64","author":"Ojeda-Fernandez","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"2026102121380263700_aajag138-B9","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3899\/jrheum.191094","article-title":"Risk of renal failure within 10 or 20 years of systemic lupus erythematosus diagnosis","volume":"48","author":"Petri","year":"2021","journal-title":"J Rheumatol"},{"key":"2026102121380263700_aajag138-B10","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1177\/0961203315627202","article-title":"Overall and cause-specific mortality in systemic lupus erythematosus: an updated meta-analysis","volume":"25","author":"Lee","year":"2016","journal-title":"Lupus"},{"key":"2026102121380263700_aajag138-B11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.55563\/clinexprheumatol\/x3s9td","article-title":"From first symptoms to diagnosis of systemic lupus erythematosus: mapping the journey of patients in an observational study","volume":"41","author":"Kapsala","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"2026102121380263700_aajag138-B12","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1177\/0961203320983445","article-title":"Delayed diagnosis adversely affects outcome in systemic lupus erythematosus: cross sectional analysis of the Lula cohort","volume":"30","author":"Kernder","year":"2021","journal-title":"Lupus"},{"key":"2026102121380263700_aajag138-B13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/ndt\/gfad154","article-title":"Chronic kidney disease: the missing concept in the 2019 EULAR\/ERA-EDTA recommendations for lupus nephritis","volume":"39","author":"Rojas-Rivera","year":"2023","journal-title":"Nephrol Dial Transplant"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/joneph\/article-pdf\/39\/7\/1462\/70633418\/aajag138.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/joneph\/article-pdf\/39\/7\/1462\/70633418\/aajag138.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:38:08Z","timestamp":1792633088000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/39\/7\/1462\/8760975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":13,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,8,13]]},"published-print":{"date-parts":[[2026,10,22]]}},"URL":"https:\/\/doi.org\/10.1093\/joneph\/aajag138","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,8,13]]}}}